The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA.

Human secretory leukocyte protease inhibitor (hSLPI) is produced by epithelial cells at mucosal surfaces, where it regulates both the neutrophil-mediated inflammation that characterizes inflammatory diseases, and pathogens themselves via both antiprotease and "defensin-like" activities. Additionally, hSLPI may regulate other processes such as cutaneous desquamation and placental invasiveness. To better understand the primary physiologic roles of SLPI, it will be important to establish a genetically tractable animal model, the most attractive candidate being the mouse. In this report, the cloning and characterization of murine (m) SLPI is described. mSLPI is encoded by a single copy gene, and appears structurally highly similar to hSLPI. At the same time, significant differences between mSLPI and hSLPI are presented, notably a difference in expression pattern, and a structural difference in the protease binding site that correlates with a difference in the spectrum of protease inhibiton. Such species-specific evolution of this protease inhibitor is notable given that species-specific structure-function differences have previously been reported for the alpha-1 antitrypsin family.

[1]  S. Moore,et al.  The expression and characterization of five recombinant murine alpha 1-protease inhibitor proteins. , 1996, Biochemical and biophysical research communications.

[2]  J. Kramps,et al.  L-Pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. , 1983, Scandinavian journal of clinical and laboratory investigation.

[3]  J. Travis,et al.  Bioengineering: α1-Proteinase Inhibitor Site-Specific Mutagenesis , 1996 .

[4]  A. Baici,et al.  Antileukoprotease Inhibits Stratum Corneum Chymotryptic Enzyme , 1996, The Journal of Biological Chemistry.

[5]  F. Lottspeich,et al.  The acid‐stable proteinase inhibitor of human mucous secretions (HUSI‐I, antileukoprotease) , 1986, FEBS letters.

[6]  S. Eriksson.  A 30-Year Perspective on α1-Antitrypsin Deficiency , 1996 .

[7]  H. Sinohara,et al.  Inhibitory Spectrum of Mouse Contrapsin and α-1-Antitrypsin against Mouse Serine Proteases , 1983 .

[8]  S. Tokura,et al.  The action of trypsin on synthetic chromogenic arginine substrates. , 1979, Journal of biochemistry.

[9]  J. Melrose,et al.  A comparative study of the low-molecular mass serine proteinase inhibitors of human connective tissues. , 1992, Biological chemistry Hoppe-Seyler.

[10]  G. Steffens,et al.  Antibacterial activity of antileukoprotease , 1996, Infection and immunity.

[11]  R. Zitnik,et al.  Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. , 1994, Journal of immunology.

[12]  B. Faller,et al.  Heparin-induced conformational change and activation of mucus proteinase inhibitor. , 1992, Biochemistry.

[13]  C. Vogelmeier,et al.  Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity. , 1996, Chest.

[14]  B. Casslén,et al.  Inhibitors of Trypsin, Chymotrypsin and Elastase in Human Uterine Fluid , 1986, Acta obstetricia et gynecologica Scandinavica.

[15]  R. Simmen,et al.  Complementary DNA cloning and regulation of expression of the messenger RNA encoding a pregnancy-associated porcine uterine protein related to human antileukoproteinase. , 1990, Molecular endocrinology.

[16]  E. G. Delmar,et al.  A sensitive new substrate for chymotrypsin. , 1979, Analytical biochemistry.

[17]  J. Dijkman,et al.  Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  H. Burkhardt,et al.  Purification of a serine-proteinase inhibitor from human articular cartilage. Identity with the acid-stable proteinase inhibitor of mucous secretions. , 1991, The Biochemical journal.

[19]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[20]  W. Kisiel,et al.  Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. , 1996, Biochemistry.

[21]  B. Wieringa,et al.  SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. , 1993, The Journal of biological chemistry.

[22]  M. T. Brewer,et al.  Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. , 1986, Nucleic acids research.

[23]  M. Jordana,et al.  Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. , 1994, American journal of respiratory cell and molecular biology.

[24]  T. Nakamura,et al.  Partial purification and characterization of 'injurin-like' factor which stimulates production of hepatocyte growth factor. , 1994, Biochimica et biophysica acta.

[25]  J. Dijkman,et al.  Tissue distribution of antileukoprotease and lysozyme in humans. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  V. Wahn,et al.  Effects of Native and Oxidation-Resistant Secretory Leukoprotease Inhibitor on Cystic Fibrosis Sputum: Inhibition of Neutrophil Elastase Activity and of Sputum-Induced Secretion from Porcine Tracheal Submuc , 1996, Pediatric Research.

[27]  K. Ohlsson,et al.  Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F Borriello,et al.  Multiple murine alpha 1-protease inhibitor genes show unusual evolutionary divergence. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[30]  Y. Aoki,et al.  Purification and characterization of novel trypsin-like serine proteases from mouse spleen. , 1996, Journal of biochemistry.

[31]  R. Huber,et al.  The 2.5 A X‐ray crystal structure of the acid‐stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha‐chymotrypsin. , 1988, The EMBO journal.

[32]  M. D. Young,et al.  Large-Scale Refolding of Secretory Leukocyte Protease Inhibitor , 1991 .

[33]  R. Lehrer,et al.  Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils , 1993, Infection and immunity.

[34]  E. Christophers,et al.  Antileukoprotease in psoriatic scales. , 1993, The Journal of investigative dermatology.

[35]  W. Groutas,et al.  Inhibitors of human neutrophil cathepsin G: structural and biochemical studies. , 1992, Archives of biochemistry and biophysics.

[36]  L. Smith,et al.  Ontogeny, immunocytochemical localization, and biochemical properties of the pregnancy-associated uterine elastase/cathepsin-G protease inhibitor, antileukoproteinase (ALP): monospecific antibodies to a synthetic peptide recognize native ALP. , 1992, Endocrinology.

[37]  R. Crystal,et al.  Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester. , 1994, The Journal of clinical investigation.

[38]  H. Lilja,et al.  Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. , 1995, Journal of andrology.

[39]  D. Johnson,et al.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases. , 1985, The Biochemical journal.

[40]  R. Simmen,et al.  Chromosomal organization of the gene encoding porcine antileukoproteinase and functional analysis of the promoter region in endometrial and placental cells , 1993, Molecular and Cellular Endocrinology.

[41]  A. Joseph,et al.  Regulation of scatter factor production via a soluble inducing factor , 1994, The Journal of cell biology.

[42]  J. Repine,et al.  Proteases, protease inhibitors and protease-derived peptides. Importance in human pathophysiology and therapeutics. Symposium proceedings. Snowmass, Colorado, August 1992. , 1993, Agents and actions. Supplements.

[43]  J. Melrose,et al.  Secretory leucocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes. , 1993, European journal of biochemistry.

[44]  C. H. Lee,et al.  Distribution of secretory leukoprotease inhibitor in the human nasal airway. , 1993, The American review of respiratory disease.

[45]  F. Borriello,et al.  Multiple murine α_1-protease inhibitor genes show unsual evolutionary divergence , 1991 .

[46]  S. Simon,et al.  Functions of the N-terminal domain of secretory leukoprotease inhibitor. , 1994, Biochemistry.

[47]  M. Plotnick,et al.  Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin. , 1996, Archives of biochemistry and biophysics.

[48]  J. Bieth,et al.  In vivo significance of kinetic constants of protein proteinase inhibitors. , 1984, Biochemical medicine.

[49]  J. Potempa,et al.  The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.

[50]  K. Matsumoto,et al.  Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Ermolieff,et al.  Mapping the heparin-binding site of mucus proteinase inhibitor. , 1995, Biochemistry.